[Epidemiology of Epstein-Barr virus (EBV) infection and EBV-associated diseases].
Maeda
Akihiko
A
Department of Pediatrics, Program of Bio-signaling and Infection Control, Kochi Medical School, Kochi University.
Sato
Tetsuya
T
Wakiguchi
Hiroshi
H
D000367:Age Factors; D000914:Antibodies, Viral / Q000097:blood*; D000956:Antigens, Viral / Q000276:immunology*; D002051:Burkitt Lymphoma / Q000453:epidemiology; D036022:Capsid Proteins / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006689:Hodgkin Disease / Q000453:epidemiology / Q000821:virology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D007244:Infectious Mononucleosis / Q000453:epidemiology*; D007564:Japan / Q000453:epidemiology; D051359:Lymphohistiocytosis, Hemophagocytic / Q000453:epidemiology / Q000821:virology; D008232:Lymphoproliferative Disorders / Q000453:epidemiology; D016036:Seroepidemiologic Studies
D000914:Antibodies, Viral; D000956:Antigens, Viral; D036022:Capsid Proteins; C041788:Epstein-Barr viral capsid antigen; D007074:Immunoglobulin G